Results of a multinational trial show that a 5-day course of nitrofurantoin may produce better outcomes in women with uncomplicated lower urinary tract infection (UTI) than a single dose of fosfomycin.
A study from Belgium has found that women with typical symptoms of urinary tract infection (UTI) may still be infected with the uropathogen Escherichia coli despite a negative culture result.
In a Swiss comparative trial, diclofenac was found to be inferior to norfloxacin for treatment of urinary tract infection (UTI).
Findings from a recent study indicate that trimethoprim 200 mg BID for 3 or 7 days is the most effective antibiotic for uncomplicated urinary tract infection (UTI) when levels of local resistance to the drug are
This article summarizes guidelines for diagnosis and treatment, highlighting special considerations for management of OAB across a woman’s life span.
Ob/gyns have witnessed how development of antibiotic resistance has affected disease management in our specialty. Increased resistance of Neisseria. Gonorrhea (N. gonorrhea) to penicillins and quinolones, emergence of methicillin-resistant staphylococcus aureus (MRSA) and resistance of Group B Streptococcus to erythromycin and clindamycin have led us to modify our antibiotic treatment regimens.
Interstitial cystitis/bladder pain syndrome (IC/BPS) is now recognized as a common etiology in women with chronic pelvic pain.